Batas v. Prudential Insurance Co. of America

281 A.D.2d 260, 724 N.Y.S.2d 3, 2001 N.Y. App. Div. LEXIS 3045
CourtAppellate Division of the Supreme Court of the State of New York
DecidedMarch 20, 2001
StatusPublished
Cited by49 cases

This text of 281 A.D.2d 260 (Batas v. Prudential Insurance Co. of America) is published on Counsel Stack Legal Research, covering Appellate Division of the Supreme Court of the State of New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Batas v. Prudential Insurance Co. of America, 281 A.D.2d 260, 724 N.Y.S.2d 3, 2001 N.Y. App. Div. LEXIS 3045 (N.Y. Ct. App. 2001).

Opinion

—Order, Supreme Court, New York County (Herman Cahn, J.), entered May 28, 1999, which, in an action involving the provision of benefits under health insurance policies issued or administered by defendants, granted in part and denied in part defendants’ motion to dismiss the complaint, modified, on the law, to reinstate the sixth cause of action, and otherwise affirmed, without costs.

The facts are fairly set forth by the dissent. We would note, however, that plaintiffs bring this action on their own behalf and as representatives of a class of all subscribers to health care plans offered by defendants (Prudential). We also note that neither party challenges the liberal standard applied by [261]*261the IAS court wherein, “[o]n a motion to dismiss for failure to state a cause of action, the court must accept all the facts alleged as true, accord the plaintiff the benefit of every possible inference, not evaluate the merits of the case, and determine only whether the facts as alleged fit within any cognizable legal theory (Leon v Martinez, 84 NY2d 83).”

Applying that standard, plaintiffs’ causes of action for breach of contract, fraud and violations of General Business Law § 349 (a) and § 350 were properly sustained over defendants’ objection that, under Public Health Law § 4406, the responsibility for regulating the contracts of Health Maintenance Organizations (HMO’s) lies with the Commissioner of the Department of Health. Nothing in that section or elsewhere in the statutory scheme suggests a clear legislative intent to preempt common-law or other rights and remedies (see, Hechter v New York Life Ins. Co., 46 NY2d 34, 39; cf., Karlin v IVF Am., 93 NY2d 282, 292-293). Nor has plaintiffs’ challenge to the utilization review procedures that defendants used in connection with plaintiffs’ hospital stays, but which allegedly were not those promised in plaintiffs’ contracts, been mooted by the enactment of statutorily mandated utilization review procedures in Public Health Law article 49 (see, Public Health Law § 4907). Plaintiffs’ allegations are also sufficient to show that the two named defendants are alter egos (see, Van Valkenburgh, Nooger & Neville v Hayden Publ. Co., 30 NY2d 34, 42, cert denied 409 US 875).

Plaintiffs’ allegations that defendants did not conduct the utilization review procedures that they promised in their contracts state a cause of action for breach of contract. Such allegations do not implicate the “filed rate doctrine” since they neither challenge the reasonableness of the filed rate nor claim that plaintiffs should have been treated differently from other subscribers (see, Kross Dependable Sanitation v AT&T Corp., 268 AD2d 874, 874-875). Although plaintiffs sustained no out-of-pocket costs, actual injury is sufficiently alleged in the nonreceipt of promised health care, for which restitution of premiums paid may be an appropriate remedy.

Plaintiffs’ fraud claim, which is based on defendants’ alleged misrepresentation of facts in materials used to induce potential subscribers to obtain defendants’ health policies, is not duplicative of plaintiffs’ breach of contract claim (see, Rosen v Spanierman, 894 F2d 28, 35). Plaintiffs also adequately plead reliance, and are not required at the pleading stage to set forth with particularity the materials they relied on.

Plaintiffs’ breach of fiduciary duty claim was properly [262]*262dismissed on the ground that their allegations are insufficient to show that defendants sought to gain their trust and confidence. As acknowledged by plaintiffs on appeal, the sole remaining basis for such cause of action is the allegation that defendants failed to disclose to their policyholders that they based their determination of what is medically necessary on utilization review guidelines — including the Milliman & Robertson Guidelines — which allegedly conflict with generally accepted medical standards and usurp the role of their own primary care physicians. The crux of plaintiffs’ claim is that because current subscribers must decide éach year whether to remain in the Prudential health care system, defendants breach the fiduciary duties owed to such subscribers by continuing to misrepresent their utilization review procedures.

The dissent concludes that because of the shocking factual allegations of the complaint, stating in essence that plaintiffs were prevented from receiving timely and necessary treatment for serious medical conditions, plaintiffs’ fourth cause of action seeking to impose a fiduciary duty on a health insurer in this context should be read to constitute a viable cause of action by the substitution of the words “duty of good faith” instead of “fiduciary duty.” Such argument relies in large part upon the recent decision in Pegram v Herdrich (530 US 211), a case cited by none of the parties on appeal, which involved an HMO dispute under ERISA (Employee Retirement Income Security Act of 1974). In urging such alternative basis for relief, the dissent acknowledges that a fiduciary duty under ERISA is inapplicable to defendants here, but argues that its existence has some relevance when considering whether medical insurers may be considered to have a fiduciary duty to their policyholders.

However, without deciding the issue, all the Supreme Court stated, in a footnote, in dicta, was that “it could be argued” that an HMO is a fiduciary insofar as it has discretionary authority to administer its health insurance plan and so would be obligated to disclose characteristics of the plan if that information affects beneficiaries’ material interests (530 US 211, 227 n 8, citing Glaziers & Glassworkers Union Local No. 252 Annuity Fund v Newbridge Secs., 93 F3d 1171, 1179-1181 [“discussing the disclosure obligations of an ERISA fiduciary” (emphasis added)]).

Relying on an HMO’s possibly arguable obligation to “disclose characteristics of the plan * * * that * * * affects beneficiaries’ material interests,” (id.) the dissent concludes that it is understandable that a policyholder might assume that her [263]*263medical insurer’s authority to administer its insurance plan creates a comparable fiduciary duty under the common law.

However, in Pegram, the sole case relied upon as a possible basis for imposing a fiduciary duty on an HMO pursuant to ERISA, the Supreme Court, as recognized by the dissent, specifically held that “mixed eligibility” decisions of this type, i.e. a combination of “eligibility” and “treatment” decisions, are not fiduciary decisions under ERISA (supra, at 237). As one commentator has noted: “Recognizing that Congress has promoted HMOs as an institution for many years, and that these decisions are very different from traditional common law fiduciary decisions, the Court held that mixed eligibility decisions by HMO physicians are not fiduciary decisions under ERISA.” (Scott M. Riemer, Outside Counsel, HMOs Face a Post-‘Pegram’ World, NYLJ, July 13, 2000, at 1, col 1, at 36, col 5.)

The Supreme Court, in Pegram (supra, 530 US, at 231) specifically doubted that Congress would ever have thought of a mixed eligibility decision as fiduciary in nature because, at common law, fiduciary duties characteristically attach to decisions from managing assets and distributing property to beneficiaries.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Lefruy v. Weeks
2025 NY Slip Op 51541(U) (New York Supreme Court, Queens County, 2025)
Hobish v. AXA Equit. Life Ins. Co.
43 N.Y.3d 442 (New York Court of Appeals, 2025)
Florence Capital Advisors, LLC v. Thompson Flanagan & Co., LLC
2023 NY Slip Op 01358 (Appellate Division of the Supreme Court of New York, 2023)
Attias v. Carefirst, Inc.
District of Columbia, 2019
Attias v. Carefirst, Inc.
365 F. Supp. 3d 1 (D.C. Circuit, 2019)
PHL Variable Ins. Co. v. Mahler
321 F. Supp. 3d 392 (E.D. New York, 2018)
Uddoh v. United Healthcare
254 F. Supp. 3d 424 (E.D. New York, 2017)
Coöperative Centrale Raiffeisen-Boerenleenbank B.A., "Rabobank Intl.," N.Y. Branch v. Atradius Credit Ins. N.V.
2017 NY Slip Op 2606 (Appellate Division of the Supreme Court of New York, 2017)
Fero v. Excellus Health Plain, Inc.
236 F. Supp. 3d 735 (W.D. New York, 2017)
Aragona v. Allstate Insurance
41 Misc. 3d 242 (New York District Court, 2013)
Prickett v. New York Life Insurance
896 F. Supp. 2d 236 (S.D. New York, 2012)
Banco Multiple Santa Cruz v. Moreno
888 F. Supp. 2d 356 (E.D. New York, 2012)
Muller-Paisner v. Tiaa
881 F. Supp. 2d 579 (S.D. New York, 2012)
In re WellPoint, Inc. Out-of-Network "UCR" Rates Litigation
865 F. Supp. 2d 1002 (C.D. California, 2011)
MBIA Insurance v. GMAC Mortgage LLC
30 Misc. 3d 856 (New York Supreme Court, 2010)

Cite This Page — Counsel Stack

Bluebook (online)
281 A.D.2d 260, 724 N.Y.S.2d 3, 2001 N.Y. App. Div. LEXIS 3045, Counsel Stack Legal Research, https://law.counselstack.com/opinion/batas-v-prudential-insurance-co-of-america-nyappdiv-2001.